Kyowa Kirin Co., Ltd.

This study is checking on patients for up to five years after they finished a previous trial for a drug called romiplostim, which treats aplastic anemia. The goal is to see if the treatment's benefits last long-term and to watch for any delayed side effects or health changes. It …

This study is testing an experimental drug called ME-401 in Japanese patients whose slow-growing B-cell lymphoma has come back or stopped responding to at least two prior treatments. The main goal is to see how well the drug shrinks the cancer and how safe it is for patients. Res…

This study is testing whether a new eye drop called KHK4951 can safely help control vision loss in people with 'wet' age-related macular degeneration (AMD). It will involve about 180 participants who have not recently received certain other eye injections. The main goal is to see…

This study is testing whether a new eye drop called KHK4951 can safely reduce swelling in the retina and improve vision for people with diabetic macular edema (DME). It involves about 150 adults with DME and compares the eye drops to a standard treatment. The main goal is to see …

This is the first human study of an experimental drug called KK4277 for lupus. Researchers are testing the safety and side effects of single and multiple doses in healthy volunteers and people with different types of lupus. The study will also measure how much of the drug gets in…

This study aims to observe 226 patients with X-linked hypophosphatemia (XLH), a rare genetic bone disorder, for up to 10 years. Researchers will track the disease's natural progression, the physical and emotional burden on patients, and the long-term effects of treatments. The go…